Skip to Content

Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

9 of 10 U.S. Teens Don't Get Enough Exercise

Over 90 percent of U.S. high school students don't get enough exercise to stay fit and healthy, and the pattern persists after they graduate, a new study finds. The researchers followed students at 44 high schools for four years, and found that only 9 percent met current exercise recommendations throughout that time. For the most part, those habits...

Posted today in Medical

Cancer Treatment More Likely to Leave Blacks in Debt

Black cancer survivors are more likely than whites to wind up in debt or forego treatment due to cost, a new study finds. "More than 1.6 million adults are diagnosed with cancer in the United States each year, and many face some form of financial hardship related to cancer and cancer treatment, even when they're insured," said study author Theresa...

Posted 3 days ago in New Drug Approvals

FDA Approves Expanded Indications for Ilaris (canakinumab) for Three Rare Periodic Fever Syndromes

The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for rare and serious auto-inflammatory diseases in adult and pediatric patients: Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS); Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD);...

Posted yesterday in New Drug Approvals

FDA Approves Stelara (ustekinumab) for Treatment of Adults with Moderately to Severely Active Crohn's Disease

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved Stelara (ustekinumab) for the treatment of moderately to severely active Crohn's disease in adults (18 years or older) who have failed or were intolerant to treatment with immunomodulators or corticosteroids but never failed treatment with a tumor necrosis...

Posted today in Medical

Always Feeling Lonely? Maybe It's in Your DNA

People with a lifelong inclination towards loneliness can probably place at least some of the blame on their genes, a large analysis suggests. The finding stems from a study involving nearly 11,000 men and women aged 50 and older. All were participants in a U.S. National Institute on Aging study focused on issues related to health, retirement and aging. Honing...

Posted today in Medical

Is Morning Sickness a Good Thing?

While morning sickness may make you miserable in the early months of your pregnancy, it can signal that your baby is healthy and normal, new research shows. In the study, those who endured the nausea and vomiting of morning sickness were 50 percent to 75 percent less likely to experience a pregnancy loss. The review focused on women who'd already lost...

Posted today in Medical

Many Patients Enter Cancer Trials With Unrealistic Expectations

Many cancer patients hold unrealistic hopes when they decide to join early stage clinical trials of experimental treatments, new research shows. These trials -- known as phase 1 trials -- evaluate the safety and possible benefits of treatments that have never before been tested on people. Many of these trials are limited to patients who have advanced...

Posted today in Medical

Amjevita Approved to Treat Inflammatory Diseases

Amjevita (adalimumab-atto) -- a biosimilar drug similar to the popular anti-inflammatory drug Humira -- has been approved by the U.S. Food and Drug Administration. Amjevita has been approved for moderate-to-severe rheumatoid arthritis; psoriatic arthritis; ankylosing spondylitis (an arthritis that affects the spine); Crohn's disease; ulcerative colitis;...

Posted today in Medical

Can Pregnancy Problems Foretell Future Health Risks?

Some pregnancy complications may signal a higher risk of health problems later in life, according to a heart specialist. High blood pressure (hypertension) or diabetes that develops during pregnancy usually gets better soon after delivery. But women who've had these conditions aren't off the hook, said Dr. Monika Sanghavi, a cardiologist at UT Southwestern...

Posted today in Medical

'Spare Tire' May Be Tougher on Your Heart Than 'Love Handles'

Belly fat -- especially hidden fat deep in the gut -- may indicate increased risk for heart disease, a new study suggests. The six-year study of more than 1,000 adults found people with a "spare tire" in their midsection had a greater risk for heart disease compared to those with visible flab elsewhere under the skin -- or "love handles." "Adipose...

Read more news...

Recently added consumer and prescribing information: Yosprala, Troxyca ER, Adlyxin, Xiidra, Epclusa, Byvalson, Zinbryta, Probuphine, Tecentriq, Bevespi Aerosphere

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

Posted in Blog

Drugs.com the First Major Consumer Health Publisher to Implement Full HTTPS Encryption

Drugs.com is pleased to announce the introduction of full HTTPS encryption for all web site visitors. With this significant and important change, nearly 70 million monthly visitors will have access to critical health and medicine information in a safe, secure and private environment. Why HTTPS Encryption? Almost everything you do on the Internet leaves a digital […]

Posted in Blog

Off-Label or Off-Limits? Should You Use A Drug For An Unapproved Use?

Off-Label Drug Use: What Is It? You may be surprised to learn that you have probably been prescribed a medication “off-label” at one point or another by your doctor. Maybe you’ve heard of “off-label” drug use in the news, but what does this really mean? “Off-label” use of a drug refers to prescribing a medication […]

See more blog posts or follow us on twitter.

Hide